Breaking News
March 22, 2019 - Alzheimer’s patients using antiepileptic drugs have twice the risk of pneumonia, study shows
March 22, 2019 - Skin diseases may be more prevalent than previously thought
March 22, 2019 - Overall rates of death from breast cancer are falling across the EU
March 22, 2019 - Novel plasmid could hold key to control of mosquito-borne illness
March 22, 2019 - Female Emergency Physicians Paid Less Than Males
March 22, 2019 - Estimated average glucose (eAG): MedlinePlus Medical Encyclopedia
March 22, 2019 - Experimental drug could be new option for type 2 diabetes
March 22, 2019 - Five Things To Know About The Electronic Health Records Mess
March 22, 2019 - TMJ disorders could be treated with tissue-engineered implants after successful animal study
March 22, 2019 - Team-based approach is key to successful care of pregnant women with heart failure
March 22, 2019 - Study identifies gene variant associated with accelerated cellular aging
March 21, 2019 - Salk scientists show how background noise from neurons can interrupt focused attention
March 21, 2019 - New class of drugs could help treat patients diagnosed with ovarian cancer
March 21, 2019 - Tecentriq Approved for Small Cell Lung Cancer
March 21, 2019 - Adipocyte glucocorticoid receptors play a role in developing steroid diabetes
March 21, 2019 - Climate change can affect nutrient content of crops, harming human health
March 21, 2019 - Podcast: KHN’s ‘What The Health’ Surprise! Fixing Surprise Medical Bills Is Harder Than it Looks
March 21, 2019 - Chemistry researchers patent new method for making anti-leukemia compounds
March 21, 2019 - UIC scientists identify hidden proteins in bacteria
March 21, 2019 - New Australian drug trial achieves remarkable results in patients with acute myeloid leukemia
March 21, 2019 - Females live longer when they have help raising offspring
March 21, 2019 - How did orthodontists sell orthodontics?
March 21, 2019 - In the Spotlight: From dietitian to physician assistant student
March 21, 2019 - The CRISPR Revolution: What You Need to Know
March 21, 2019 - FDA Chief Calls For Stricter Scrutiny Of Electronic Health Records
March 21, 2019 - Combined glucocorticoid and antioxidant therapy could benefit premature babies
March 21, 2019 - Low levels of certain eye proteins could serve as predictor for Alzheimer’s
March 21, 2019 - Post-traumatic holocaust survivors transmit negative views on aging to offspring
March 21, 2019 - City of Hope receives $7.5 million in grant awards to study cutaneous T cell lymphoma
March 21, 2019 - New video game-led training device helps stroke survivors regain arm mobility
March 21, 2019 - Compounds in coffee could slow prostate cancer growth
March 21, 2019 - New mobile DNA element in Wolbachia may contribute to improved disease control strategies
March 21, 2019 - Phase 2 Clinical Trial of Bermekimab Shows Potential New Standard of Care for Treatment of Hidradenitis Suppurativa, Including Significant Pain Reduction without Antibiotics
March 21, 2019 - More than one-third of patients risk major bleeding by doubling up on blood thinners
March 21, 2019 - A skeptical look at popular diets: Thumbs up for Mediterranean
March 21, 2019 - PTSD After Cardiac Arrest Predicts More Heart Trouble
March 21, 2019 - Role of immunological imprinting in elicitation of new antibodies
March 21, 2019 - Breast cancer relapse predictor tool may soon be a reality
March 21, 2019 - New computer program developed by TGen lights up cancer-causing genetic mutations
March 21, 2019 - FDA warns two breast implant makers for failure to comply with post-approval study requirements
March 21, 2019 - Butler Hospital receives COBRE grant to enhance research on neuropsychiatric illnesses
March 21, 2019 - Majority of osteoporosis clinical practice guidelines ignore patients’ voices
March 21, 2019 - Generic messages don’t help patients to lose weight
March 21, 2019 - Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
March 21, 2019 - Two-drug combos using popular calcium channel blocker show superiority in lowering BP
March 21, 2019 - First-in-human pilot study shows positive results for ‘bacteria-phobic’ catheter
March 21, 2019 - Itamar Medical launches next-generation WatchPAT system for home sleep apnea testing
March 21, 2019 - Study estimates health and economic impacts of healthy food prescriptions
March 21, 2019 - Detecting fungal disease in crops with multispectral imaging system
March 21, 2019 - MIT announces creation of the Alana Down Syndrome Center
March 21, 2019 - Next-generation LVAD device clinically superior, safer for heart failure patients
March 21, 2019 - Allergan Announces FDA Approval of Avycaz (ceftazidime and avibactam) for Pediatric Patients
March 21, 2019 - Mutations in noncoding genes could play big role in regulating cancer, study finds
March 21, 2019 - A medical student’s thoughts on Match Day
March 21, 2019 - Are eggs good or bad for you?
March 21, 2019 - New analysis reveals precision oncology insights for colorectal cancer
March 21, 2019 - Pollutants appear to weaken immune system and increase pathogen virulence
March 21, 2019 - Researchers develop and validate scale for rating severity of mononucleosis
March 21, 2019 - Scientists identify generation of key immune response in mice on introducing solid food
March 21, 2019 - New nanomaterial could restore internal structure of damaged bones
March 21, 2019 - Selective destruction of prostate tumor as effective as complete prostate removal
March 21, 2019 - 2011 to 2015 Saw Increase in Psychiatric ED Visits for Youth
March 21, 2019 - Tapeworm drug targets common vulnerability in tumor cells
March 21, 2019 - WVU researcher discovers higher suicide rate among Medicaid-insured youth
March 21, 2019 - Off the beaten path for global health residency
March 21, 2019 - European Parliament’s report calls on EU to develop policies to regulate endocrine-disrupting chemicals
March 21, 2019 - Women with undiagnosed diabetes in pregnancy more likely to experience stillbirths
March 21, 2019 - Fish consumption can help prevent asthma, study reveals
March 21, 2019 - Royal Holloway professors to lead new to research into curing Neurofibromatosis type 1
March 21, 2019 - NSF offers grant to improve treatment approaches for pelvic organ prolapse
March 21, 2019 - Your Apple Watch Might Help Spot a Dangerous Irregular Heartbeat
March 21, 2019 - Research team uncovers critical new clues about what goes awry in autistic brains
March 21, 2019 - From March Madness to medicine with help from mentors
March 21, 2019 - Mental health disorders among young adults may be on the increase
March 21, 2019 - New study examines smarter automatic defibrillator
March 21, 2019 - UC Riverside research shows how natural selection favors cheaters
March 21, 2019 - Mother’s diet during pregnancy can impact lung-specific genes of her offspring
March 21, 2019 - AeroForm Tissue Expanders makes breast reconstruction after mastectomy more comfortable
March 21, 2019 - New project focuses on creating more responsive, intuitive prosthetics
March 21, 2019 - New case study describes adolescent patient with rapid-onset schizophrenia and Bartonella infection
With philanthropic gifts, Stanford poised to make major advances in neurosciences | News Center

With philanthropic gifts, Stanford poised to make major advances in neurosciences | News Center

image_pdfDownload PDFimage_print

Stanford will accelerate the pace of discovery about the human brain and advance innovative, interdisciplinary brain science thanks to nearly $250 million in recent gifts from philanthropists from the United States, Asia and Europe.

In recognition of the lead gift from alumna Clara Wu Tsai and her husband, Joe Tsai, the Stanford Neurosciences Institute is changing its name to the Wu Tsai Neurosciences Institute.

The institute’s goal is to better understand how the brain functions, both in health and disease, and to pave the way for new treatments for neurological and psychiatric diseases such as depression, anxiety and Alzheimer’s. The funds, raised since the institute was established in 2013, provide support to scale up research initiatives; expand resources for faculty, students, postdoctoral scholars and new technologies; and complete an interdisciplinary research complex where scientists from across campus can meet and collaborate.

Stanford President Marc Tessier-Lavigne, PhD, a neuroscientist himself, said the gifts come at a pivotal time.

“We are on the threshold of a very promising era, as we make discoveries about the living brain that were previously unimaginable,” Tessier-Lavigne said. “Nearly 450 faculty members from a range of fields are already engaged in the neurosciences and brain-related research at Stanford, making it one of our most vibrant areas of inquiry on campus. These foundational investments uniquely position our scientific community and universitywide institute to advance new breakthroughs. I am deeply thankful for the vision and generosity of our donors, including Clara Wu Tsai and Joe Tsai, who understand the potential of this research to improve brain health and human well-being.”

Gift to advance brain discoveries

Clara Wu Tsai served on a presidential task force that helped shape the Stanford Neurosciences Institute and Stanford ChEM-H (Chemistry, Engineering & Medicine for Human Health). She said the concentration of experts from many fields within walking distance of one another on one campus and the university’s ability to harness this collective knowledge were key factors that she and her husband took into account when deciding to invest in the neurosciences at Stanford.

“Joe and I believe Stanford is uniquely positioned to drive breakthrough discoveries about the brain, translate them into effective therapies and train future scientists of the world,” Wu Tsai said. “Ultimately, we hope the research undertaken at the Wu Tsai Neurosciences Institute will lead to cures and treatments that impact millions of people by prolonging their lives and making them more fulfilling and productive.”

Wu Tsai earned a bachelor’s degree in international relations and a master’s degree in international policy studies at Stanford, both in 1988, as well as an MBA at Harvard. She then pursued a career in business and finance as an executive at American Express and at Taobao, China’s largest online shopping site.

The future of Stanford neuroscience

At Stanford, Clara Wu Tsai is an active member of the advisory council that helps guide university institutes focused on the interdisciplinary life sciences. She also co-chairs the advisory cabinet for the neurosciences institute and serves on the university’s Global Advisory Council. Previously, she served on the advisory council for Stanford Bio-X.

Joe Tsai is executive vice chairman and one of the founders of Alibaba Group, a global Internet technology company based in China. Alibaba has businesses in digital commerce, entertainment, cloud computing, logistics and financial technology.

Together, Joe and Clara pursue philanthropic investments that advance knowledge, innovation, equality of opportunity and creative arts. Their work with global partners focuses on the translation of new knowledge into practical applications with human and social impact.

Platform for campuswide collaborations

In its role of fostering universitywide initiatives related to brain science, the Wu Tsai Neurosciences Institute will leverage ongoing contributions from the schools of Medicine, of Engineering and of Humanities and Sciences. These partnerships will be further enhanced when a new interdisciplinary research complex opens next year. The complex comprises two intersecting buildings: One will serve as the hub for the Wu Tsai Neurosciences Institute and the other for Stanford ChEM-H.

Breakthroughs in the neurosciences have the potential to not only improve human well-being but to guide future policies and practices that affect the criminal justice system, drug control, national defense, social welfare and education.

The 235,000-square-foot research complex is located a short walk from Stanford’s basic sciences departments, engineering and medical schools, as well as the children’s and adult hospitals. Also nearby is the James H. Clark Center, the home base of Stanford Bio-X, a cross-disciplinary venture launched in 1998 that has become a model for biosciences programs worldwide.

The Wu Tsai Neurosciences Institute is led by William Newsome, PhD, the Vincent V. C. Woo Director, who jointly led the working group for President Barack Obama’s BRAIN research initiative. Newsome said that advances in the neurosciences have the potential to transform the 21st century in the way that quantum physics and breaking the genetic code transformed the 20th century.

“Technologies invented in the last decade are making it possible for neuroscientists to acquire new kinds of information about the brain that, until recently, was the stuff of scientists’ dreams,” said Newsome, who also holds the Harman Family Provostial Professorship. “The sequencing of the human genome, new imaging techniques, optogenetics, discoveries in nanoscience and physics — all of these advances are providing critical insights into our minds and ourselves. Clara and Joe’s generous gift will help us get closer to a world where we can effectively diagnose and treat brain injury, diseases and disorders, as well as enhance brain functions to improve lives.”

Big Ideas in Neuroscience

When the neurosciences institute was launched five years ago, Newsome asked faculty to form cross-disciplinary teams around what they considered the boldest, most visionary research projects tackling challenges in brain science. More than 230 Stanford scientists and scholars presented dozens of “Big Ideas in Neuroscience” that focused on three research directions: NeuroDiscovery, NeuroEngineering and NeuroHealth. The institute selected projects with tremendous potential that were less likely to secure federal funding at this early stage of research, especially since the projects require substantive teamwork among diverse faculty experts. A second round of Big Ideas was announced last month.

Ongoing projects are looking into brain rejuvenation, addiction, neuro-technologies, brain-machine interfaces, nervous system disorders and psychiatric illness.

In addition, the institute funds modest grants and awards that support high-risk, high-reward collaborations. These include research into cognitive aging and stroke recovery, and treatments for obsessive-compulsive disorder and chronic pain. The institute also fosters teamwork through shared laboratories and collaboration spaces, as well as workshops, seminars and symposia.

Kathryn Moler, PhD, vice provost and dean of research, said the Wu Tsai Neurosciences Institute will accelerate these types of innovative and interdisciplinary campus endeavors and support collaborations with SLAC National Accelerator Laboratory, the Veterans Affairs Palo Alto Health Care System and biotech firms in Silicon Valley.

“One of the challenges of interdisciplinary research is finding effective ways for experts from different fields to work together,” Moler said. “What we are learning from Big Ideas and other cross-campus collaborations is helping to set a new standard for how to do science in the 21st century.”

New era for neurosciences at Stanford

The neurosciences institute marked its fifth anniversary Oct. 11 with a symposium titled “Natural/Artificial Intelligence.” Future plans include launching an initiative in neuro-translation to help teams of scientists move discoveries from the lab into practical applications. It will also support neuro-theory collaborations involving computer scientists, statisticians, applied physicists and engineers who want to identify fundamental principles of nervous system computation, understand how the brain’s neural network of interconnecting neurons operates and also make sense of the vast quantities of new brain data.

Newsome said there has been an explosion of interest from young scientists in collaborative brain research and that the institute will need to raise funding for more fellowships to ramp up cross-disciplinary graduate and postdoctoral training programs. The institute also aims to launch research centers that specialize in highly promising areas such as sensory neuroscience, computational neuroscience, and molecular and cellular approaches to brain disease.

“Breakthroughs in the neurosciences have the potential to not only improve human well-being but to guide future policies and practices that affect the criminal justice system, drug control, national defense, social welfare and education,” Newsome said. “I believe that the work of the Wu Tsai Neurosciences Institute will be truly transformative.”

About author

Related Articles